Polaris Partners — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
BiotechWatertown, US
Carlo Giovanni Traverso(Director)Amy W. Schulman(Executive Officer, Director)inRobert S. Langer(Director)
BoardZafi Avnur(Director)Edmund Harrigan(Director)Catherine Reynolds(Director)
Board seatAmy Schulman· per SEC Form D · $206.1M raise · filed Dec 2023
Co-investorsBill & Melinda Gates FoundationKendall Capital Partners
BiotechWaltham, US
Timothy Springer(Director)Praveen Tiprirneni(Executive Officer, Director)Robert Farrell(Executive Officer)
BoardBarbara Dalton(Director)Ramy Farid(Director)Kevin Bitterman(Director)in
Board seatAmir Nashat· per SEC Form D · $100M raise · filed Mar 2023
Co-investorsAtlas VentureOmega Funds
Cambridge, US
Board seatAlexandra Cantley· per SEC Form D · $23.2M raise · filed May 2023
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.